Ben Guill has resigned as president of the US private equity firm that specialises in the energy industry.
The Silicon Valley venture capital firm has closed its fourth fund, which will focus on more developed technology companies than those in which it typically invests.
The joint venture between Venturion Capital and former Marsh & McLennan chief Jeffrey Greenberg has closed its first fund.
The Bahrain-based manager has begun marketing its first traditional limited partnership and is targeting a first close on $400m in May, according to one investor.
The Waltham, Massachusetts-based venture capital firm has closed its fourth fund, and recently added a new general partner, Elliot Katzman, to its team of 8 investment professionals.
Donald Nelson, former investor relations head of the Boston-based life sciences venture capital firm, has left to form NelCap Advisers, his own placement agency and consulting firm.
Private equity buyout volume reached $197bn in the first quarter of 2007, while KKR accounted for a staggering 48 percent of that deal activity.
Deutsche Bank’s infrastructure division has reportedly reached the final stage in the auction of Montagu Private Equity’s UK recycling and waste management firm Cory Environmental.
Townes Pressler, co-founder of an independent oil and gas producer and former energy banker, has joined the energy-focused private equity firm as a managing director.
John Moon, a former managing director at Morgan Stanley spin-out Metalmark Capital, has joined Carlyle energy affiliate Riverstone Holdings as a managing director.
UK-listed private equity company has missed the top of its range by £600m but gearing still means it has £1bn to spend on infrastructure.
Aberdeen Property Investors’ Asia-focused vehicle has $435m in commitments—and the firm hopes to announce a final close on $600m by the second quarter.
Seoul-headquartered Doran Capital has held a first closed on its Korean real estate fund, which looks to make value-added investments throughout the country.
The US-German investment house’s latest life sciences-focused fund will invest principally in US biotechnology companies.
AIG Global Investment Group has raised $410 million for its Asia Opportunity Fund II, after investing in China, India and Korea during 2006, falling short of its $500m target.